MiSight® Clinical Study (2 of 2) (IMAGE)

McDougall Communications

MiSight® Clinical Study (2 of 2)

Caption

New four-year study data shows the significant impact of a pioneering CooperVision® MiSight® contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later. In year four, children in the original control group were refit with the myopia control lens, and then continued to be tracked separately. Use of the dual-focus contact lens -- which has alternating visual correction and treatment zones -- was effective in slowing myopia progression in both groups.

Credit

CooperVision

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.